Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has bee ...

The pharmaceutical giant named Jeffrey Legos the head of a division it is counting on to overcome investor pressure and grow ...

International drug giant GSK plc is moving its vaccine R&D and infectious disease teams to Cambridge from Maryland, and plans to expand its footprint here.

GSK plans to buy back $2.50 billion in shares and raised its midterm sales target, citing promising pipeline developments.

GSK's vaccine for shingles prevention. This new syringe presentation is designed to simplify the administration process for healthcare providers by eliminating the need to mix a powder and liquid ...

Scientists are working to create a new cancer vaccine that could “detect the undetectable” and stop the disease up to 20 years before it has the chance to develop. Pharmaceutical giant GSK and ...

5 This European regulatory review follows the file acceptance by the US FDA on 8 January 2025 for the new prefilled syringe presentation, continuing GSK’s commitment to providing solutions to ...

In 2021, GSK and Oxford initiated the Institute of Molecular and Computational Medicine, which has been at the forefront of researching new medicines. Tony Wood, chief scientific officer at GSK ...

Thank you for signing up! Did you know with an ad-lite subscription to Mansfield and Ashfield Chad, you get 70% fewer ads while viewing the news that matters to you. The Jeep Avenger is very much a ...

New shares at such a low price could add value to my existing holding in GSK. But I need to check that there is value in the stock. Such a fall could also indicate that the company is simply worth ...